本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

11.44
+1.1611.28%
盘后11.450.0100+0.09%18:54 EDT
成交量:13.77万
成交额:156.18万
市值:6,994.76万
市盈率:-0.89
高:11.76
开:10.75
低:10.62
收:10.28
数据加载中...

公司资料

公司名字:
Aligos Therapeutics, Inc.
交易所:
NASDAQ
成立时间:
2018
员工人数:
68
公司地址:
One Corporate Drive,2nd Floor,South San Francisco,California,United States
邮编:
94080
电话:
传真:
- -
简介:
Aligos Therapeutics, Inc.于2018年2月5日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,专注于开发新疗法,以解决肝病和病毒感染方面未满足的医疗需求。

董事

名称
职位
Lawrence M. Blatt
Chief Executive Officer and Director
Jack B. Nielsen
Chair and Director
Leonid Beigelman
President and Director
Carole Nuechterlein
Director
K. Peter Hirth
Director
Kathleen Sereda Glaub
Director
Peter Moldt
Director
Thomas Woiwode
Director

股东

名称
职位
Lawrence M. Blatt
Chief Executive Officer and Director
Lesley Ann Calhoun
Executive Vice President, Chief Financial Officer
Julian A. Symons
Executive Vice President, Chief Scientific Officer
Leonid Beigelman
President and Director
Lucinda Y. Quan
Executive Vice President, Chief Business Officer and General Counsel